Life sciences technology companies face a challenge that rarely appears on a slide deck: their customers are scientists. Brilliant, sceptical, time-poor scientists who need to see genuine value in their workflow before they’ll change anything. Getting that right requires someone who understands both sides of that equation intimately.
With 25 years at the intersection of medicinal chemistry, application science, and senior commercial leadership, I've worked as a scientist, a commercial leader, and now as a consultant and coach to companies shaping the future of drug discovery.
British by background and Boston-based for nearly thirty years, I’ve spent my career moving fluently between UK and US scientific and commercial cultures, a perspective that proves particularly valuable for companies navigating that crossing.
I bring the scientific depth of a PhD alongside the instinct for what makes technology genuinely resonate with the people using it. As a Chartered Chemist (CChem) and Chartered Scientist (CSci), I work with rigour. As someone who has sat on both sides of the table, I work with empathy.
I've been working on this problem long enough to know where it usually breaks down. It's rarely the technology. The result is adoption that sticks — and relationships that last.